Estrous cycle influences organ-specific metastasis of B16F10 melanoma cells.
Some clinical studies suggest that timing of surgery during specific menstrual phases may influence the chances of survival for premenopausal women with breast cancer, whereas other studies failed to find this effect. Because most breast cancer deaths are attributable to metastases, we hypothesized that aspects of the metastatic process might be sensitive to cyclic hormonal fluctuations. Our goal was to develop a mouse model to assess possible mechanisms for the effect of the menstrual cycle on metastatic ability. To separate the effects of the hormonal milieu on the host versus the cancer cells, we began by using melanoma cells. We report here that the estrous phase at the time of entry of B16F10 melanoma cells into the circulation leads to marked differences in organ-specific metastasis, suggesting that this concept merits additional study.
Vantyghem
Sharon A
SA
Department of Pathology, University of Western Ontario, and London Regional Cancer Centre, London, Ontario, Canada.
Postenka
Carl O
CO
Chambers
Ann F
AF
D000818:Animals; D004971:Estrus / Q000502:physiology*; D005260:Female; D008546:Melanoma, Experimental / Q000473:pathology / Q000556:secondary*; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D010051:Ovarian Neoplasms / Q000556:secondary